Modular Medical Inc (MODD)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$1.67-5.65%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · MODD
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Total Revenues | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 19.2 | 20.0 | 14.7 | 12.9 | 9.1 | 7.7 | 4.1 | 3.0 | 1.9 | 0.3 | — | — | — | — | — | — |
| Other Operating Expenses, Total | — | — | — | — | — | — | — | — | — | — | — | — | — | (0.0) | — | — |
| Operating Income | (27.3) | (27.6) | (19.0) | (17.5) | (13.9) | (14.9) | (7.3) | (5.3) | (2.6) | (0.7) | (0.1) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Earnings from Continuing Operations | ||||||||||||||||
| Interest Expense | — | — | — | — | — | 2.8 | 0.0 | 0.0 | — | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | — | (28.2) | (18.8) | (17.5) | (13.9) | (18.6) | (7.4) | (5.3) | (2.5) | (0.7) | (0.1) | (0.0) | (0.0) | — | — | — |
| Income Tax Expense | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | ||||||||||||||||
| Net Income | (28.0) | (28.2) | (18.8) | (17.5) | (13.9) | (18.6) | (7.4) | (5.3) | (2.5) | (0.7) | (0.1) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Per Share | ||||||||||||||||
| Basic EPS | (5.14) | (12.36) | (0.51) | (0.78) | (1.15) | (2.74) | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | (5.14) | (12.36) | (0.51) | (0.78) | (1.15) | (2.74) | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 5.5 | 2.3 | 37.0 | 22.4 | 12.1 | 6.8 | — | — | 16.6 | 13.3 | 1.7 | — | — | — | — | — |
| Diluted Weighted Avg Shares | 5.5 | 2.3 | 37.0 | 22.4 | 12.1 | 6.8 | — | — | 16.6 | 13.3 | 1.7 | — | — | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | (25.9) | (18.0) | (17.1) | (13.7) | (14.8) | (7.2) | (5.3) | (2.6) | (0.7) | — | — | — | (0.0) | (0.0) | (0.0) |
| EBIT | (27.3) | (27.6) | (19.0) | (17.5) | (13.9) | (14.9) | (7.3) | (5.3) | (2.6) | (0.7) | (0.1) | (0.0) | (0.0) | (0.0) | (0.0) | (0.0) |
| Effective Tax Rate | — | — | — | — | -0.0% | -0.0% | -0.0% | -0.0% | -0.1% | -0.2% | 0.0% | 0.0% | 0.0% | — | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.